Abbas, Leslie T.
HRN: 21-41-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/05/2022
ORAL
500mg
BID
S/P NSVD W/ Repair Of Perineal Laceration
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes